Seelos Therapeutics to Participate in the 2021 Jefferies Virtual Healthcare Conference
Seelos Therapeutics, Inc. a clinical-stage biopharmaceutical company focused on the development of therapies for central nervous system disorders and rare diseases, today announced that it will participate in the 2021 Jefferies Virtual Healthcare Conference, June 1-4, 2021 . Raj Mehra, Ph.D., Chairman and CEO, will present on Thursday, June 3rd at 10:30am ET and host 1×1 meetings. Presentation webcast registration …
Seelos Therapeutics, Inc. (Nasdaq: SEEL), a clinical-stage biopharmaceutical company focused on the development of therapies for central nervous system disorders and rare diseases, today announced that it will participate in the 2021 Jefferies Virtual Healthcare Conference, June 1-4, 2021 .
uniQure Announces First Quarter 2021 Financial Results and Highlights Recent Company Progress streetinsider.com - get the latest breaking news, showbiz & celebrity photos, sport news & rumours, viral videos and top stories from streetinsider.com Daily Mail and Mail on Sunday newspapers.
MeiraGTx Announces Participation at Upcoming Investor Conferences
BofA Securities 2021 Virtual Health Care Conference
Wednesday, May 12, 2021, 1:15 p.m. ET
2021 RBC Capital Markets Global Healthcare Conference
Wednesday, May 19, 2021, 4:50 p.m. ET
Oppenheimer s Rare & Orphan Disease Summit
Friday, May 21, 2021 (1x1 meetings only)
Live webcasts of the presentations. For conferences that offer replays, presentations will be made available for a limited time.
About MeiraGTx
MeiraGTx (Nasdaq: MGTX) is a vertically integrated, clinical stage gene therapy company with six programs in clinical development and a broad pipeline of preclinical and research programs. MeiraGTx has core capabilities in viral vector design and optimization and gene therapy manufacturing, as well as a potentially transformative gene regulation technology. Led by an experienced management team, MeiraGTx has taken a portfolio approach by licensing, acquiring and developing technologies that give depth across
Halozyme to Present at BofA Securities 2021 Virtual Health Care Conference
News provided by
Share this article
Share this article
SAN DIEGO, April 29, 2021 /PRNewswire/ Halozyme Therapeutics, Inc. (NASDAQ: HALO) today announced that Dr. Helen Torley, president and chief executive officer, will present virtually at the BofA Securities 2021 Virtual Health Care Conference on Tuesday, May 11, 2021 at 12:30 p.m. Eastern Time / 9:30 a.m. Pacific Time
An audio-only direct link of the presentation can be accessed through the Investors section of www.halozyme.com, and a recording will be made available for 6 months following the event. To access the link, please visit Halozyme s website approximately 10 minutes prior to the presentation to register and download any necessary audio software.
Hillrom to Present at the BofA Securities 2021 Virtual Health Care Conference
News provided by
Share this article
Share this article
CHICAGO, April 28, 2021 /PRNewswire/ Hillrom (NYSE: HRC) today announced that it will present at the BofA Securities 2021 Virtual Health Care Conference on Tuesday, May 11, 2021. John Groetelaars, Hillrom s president and chief executive officer, will participate in a fireside chat at 9:30 a.m. Eastern Time via webcast and will host virtual one-on-one meetings immediately following.
The live webcast of Hillrom s presentation can be found at www.hillrom.com. A recorded replay will be available after the conclusion of the live event for a period of 90 days.